Palisade Bio (PALI) EBITDA Margin Growth (3y) (2014 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,003.00 |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 12.48 Mn |
| Dec 31, 2020 | -17.53 Mn |
| Sep 30, 2020 | -8.74 Mn |
| Jun 30, 2020 | 10.79 Mn |
| Mar 31, 2020 | 17.68 Mn |
| Dec 31, 2019 | -1.97 Mn |
| Sep 30, 2019 | 13.81 Mn |
| Jun 30, 2019 | 13.58 Mn |
| Mar 31, 2019 | 13.97 Mn |
| Dec 31, 2018 | 17.78 Mn |
| Sep 30, 2018 | 15.24 Mn |
| Jun 30, 2018 | 21.77 Mn |
| Mar 31, 2018 | 7.23 Mn |
| Dec 31, 2017 | 9.82 Mn |
| Sep 30, 2017 | 7.67 Mn |
| Jun 30, 2017 | -11.58 Mn |
| Mar 31, 2017 | -17.85 Mn |
| Dec 31, 2016 | 4.88 Mn |
| Sep 30, 2016 | -6.35 Mn |
| Jun 30, 2016 | -2.45 Mn |
| Mar 31, 2016 | -26.15 Mn |
| Dec 31, 2015 | -8.16 Mn |
| Sep 30, 2015 | -22.41 Mn |
| Jun 30, 2015 | -21.49 Mn |
| Mar 31, 2015 | -15.66 Mn |
| Dec 31, 2014 | -9.86 Mn |
| Sep 30, 2014 | -7.90 Mn |